when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Immunology · news · pharmadog

← back to Immunology

News · Immunology

412 stories

Jul 22, 266 companies hiring in Cambridge nowbiospace

Jul 22, 26As Maui recovers from devastating fires, a study offers vision for new rural health modelstat

Jul 21, 26Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’biopharma dive

Jul 21, 26Novartis climbs on upbeat drug sales as key readouts loombiopharma dive

Jul 21, 26‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx dealfiercebiotech

Jul 21, 26Axiom plans Hong Kong IPO, hoping to carve new path for US biotechsbiospace

Jul 20, 26Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvalsbiospace

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 20, 26How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorbiospace

Jul 19, 26Relay Peak Research LLC Recalls Zen Principle® Moringa Capsules Because of Possible Health Riskfda recalls

Jul 17, 26Jasper gets a lifeline in merger with immune drugmaker Kirabiopharma dive

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 17, 26Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Miradorfiercebiotech

Jul 16, 26Mirador unveils part of pipeline with drug from Kira to rival Tavneosendpoints

Jul 16, 26Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsbiopharma dive

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 16, 26Chutes & Ladders—Cue lines up new CMO and research headfiercebiotech

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 updatefiercebiotech

Jul 16, 26Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trialfiercebiotech

Jul 16, 26Opinion: The growing fang-to-pharmacy pipelinestat

Jul 16, 26STAT+: CMS signals intent to revamp how it pays for clinical software and AIstat

Jul 15, 26STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosisstat

Jul 15, 26Merck ADC, in China study, shows potential to replace chemo in lung cancerbiopharma dive

Jul 15, 26Braveheart, Attovia join next wave of biotech IPOsbiopharma dive

Jul 15, 26STAT+: Celcuity’s breast cancer drug approved, its firststat

Jul 15, 26Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytrudabiospace

Jul 15, 26J&J dips despite upbeat outlook; AstraZeneca, Spero cut China dealsbiopharma dive

Jul 15, 26Nava Therapeutics emerges with $89M for lipid nanoparticlesendpoints

Jul 15, 26STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectstat

← prevpage 6 of 14next →